SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-22-002054
Filing Date
2022-06-21
Accepted
2022-06-21 19:40:52
Documents
1
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form313392002_06212022.html 3  
1 OWNERSHIP DOCUMENT form313392002_06212022.xml 3 4528
  Complete submission text file 0000921895-22-002054.txt   6110
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114
Business Address
Ma-Weaver Jacob (Reporting) CIK: 0001922140 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22873 | Film No.: 221029580